| Nov 18 |
Vera Therapeutics Appoints Jason S. Carter as Chief Legal Officer
|
| Nov 11 |
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
| Nov 11 |
Wall Street Analysts Think Vera Therapeutics (VERA) Could Surge 27.26%: Read This Before Placing a Bet
|
| Nov 11 |
Vera Therapeutics Partners with University of Michigan on the NEPTUNE Match Project and PIONEER Study
|
| Nov 8 |
Vera Therapeutics to Participate at Upcoming Investor Conferences
|
| Nov 7 |
Vera Therapeutics reports Q3 results
|
| Nov 7 |
Vera Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
|
| Oct 30 |
Vera Therapeutics prices $300M offering at $42 per share
|
| Oct 30 |
Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock
|
| Oct 29 |
Vera Therapeutics price target raised to $64 from $56 at Guggenheim
|
